GovChime
Notice ID: 1611b9bb442a49d5bcb90562d7c8a512Special Notice

AJ11--Research Project Compliance with Biosafety Regulations

Archived on December 4, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
1:00 PM UTC−05:00
Posted
November 13, 2024
Notice type
Special Notice
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)
Agency
Department of Veterans Affairs

Notice details

Office
245-NETWORK CONTRACT OFFICE 5 (36C245)
Last updated
Jan 23, 2026

Identifiers

Solicitation number
36C24525Q0106
Notice ID
1611b9bb442a49d5bcb90562d7c8a512

Description

This Intent to Sole Source announcement is posted in accordance with FAR 5.2 - Synopses of Proposed Contract Actions. Background - The proposed procurement is to ensure the Veterans Affairs Maryland Health Care System (VAMHCS) research projects are compliant with biological safety regulations and policies. Services will include consultation on existing and future regulations and requirements for research projects to be compliant with biosafety requirements; inspections to ensure compliance with regulations and providing corrective training for any deficiencies discovered. Research and Development projects are required to be compliant with all Biosafety regulations which are reported to several research oversight bodies. Professional services for research projects to be compliant with Biosafety requirements. Services that will be provided are: compliance consultations from the Biosafety Officer, Assistant Biosafety Officer, Biosafety Specialist and Biosafety Research Specialist as needed; assistance in reviewing, editing, and crafting the Veterans Affairs Maryland Health Care System Biosafety Policies and Procedures for research projects as well as responding to inquiries for such policies and procedures; staffing committees which are involved in research biosafety policies and procedures; assisting with compliance of the VAMHCS recombinant DNA research program and the Select Agent program; and inspections to ensure compliance with regulations and training for research staff discovered to be deficient. Objective VAMHCS will have direct access to the professional and technical services of the University of Maryland Environmental Health and Safety Bio-Safety team mentioned above to assist in the review and development of bio-safety-related VAMHCS Research Service policies and procedures. The Bio-Safety team will assist in responding to inquiries regarding bio-safety-related policies and procedures from regulatory officials or agencies. The Bio-Safety team will provide compliance assistance for the VAMHCS recombinant DNA research program and the VAMHCS Select Agent program. Unique Qualifications The Department of Veterans Affairs requires continuous research project support service for a responsible source. University of Maryland Environmental Health and Bio-Safety is one of the institutes within the VA geographical area with direct knowledge and understanding of the VA Bio-Safety requirements and regulations. To conduct research a number of separate oversight bodies must perform initial and periodic continuous review of the research activities and should there be any findings the oversight bodies pass them between one another to agree upon recommendations. Those recommendations are then reviewed and considered by the committees and institutional officials who are locally responsible for the conduct of the research. The VAMHCS has established Memorandums of Understanding (MOUs) with the University of Maryland, Institutional Review Board (UM IRB), with the University of Maryland, Institutional Animal Care and Use Committee (UM IACUC), and with the University of Maryland, Institutional Biosafety Committee (UM IBC) to serve as their IRB, IACUC and IBC of record. Award information - Solicitation No. 36C24525Q0106 will be presented to the contractor in accordance with the sole source authority at FAR 6.302-3 as a fixed-price contract. The period of performance shall be for one base year plus four option years. Option ordering periods are exercised as required and are not guaranteed. The anticipated Period of Performance reads as follows: Base Ordering Period (Est. Award date): 12/1/2024 11/30/2025 Est. Option Year 1: 12/1/2025 11/30/2026 Est. Option 2: 12/31/2026 11/30/2027 Est. Option 3: 12/31/2027 11/30/2028 Est. Option 4: 12/31/2028 11/30/2029 If anyone requests additional information or would like to obtain a copy of the solicitation, please contact: Veronica B. Dillard, veronica.dillard@va.gov.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

Showing 1 of 1 items

Document
Source
Agency
Posted Date
File Size
Actions
Special NoticeVETERANS AFFAIRS, DEPARTMENT OFNov 13, 2024-

Lifecycle

Solicitation:36C24525Q0106
  1. Special NoticeCurrentNov 13, 2024

    AJ11--Research Project Compliance with Biosafety Regulations

    Notice 1611b9bb442a49d5bcb90562d7c8a512 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Amendment 001 - 10/30/26 - Updated the proposal due date from 2/1/27 at 5:00 pm to 1/22/27 at 5:00 pm. Updated the Special Notice Archive date from 15 days after response date to 09/30/27. In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.
-Special Notice01/22/2027
Please see attachment. 53 total awards from the subject announcment.
-AwardedOpen
Amendment 0001 to this notice is to push out the anticipated posting of the solicitation to late November 2026. This is a pre-solicitation notice to synopsize the intention of the Defense Health Agency Contracting Activity (DHACA) to issue a Request for Proposal (RFP) for an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle covering military medical research and development services. A historical pre-solicitation notice was posted under Notice ID# HT942626RE002, although there were various delays with getting a solicitation out in Fiscal Year 2026. This notice is taking over where Notice ID# HT942626RE002 left off. No further delays are anticipated at this time for this on-ramp. The eventual RFP will be set-aside for small businesses certified under the Small Business Administration 8(a) Program. The Government anticipates making multiple new awards under this on-ramp, and all new awards will align with the existing unrestricted contract vehicle. This notice is not a request for proposals and does not commit the Government to any contractual agreement. The OMNIBUS IV contract vehicle was awarded under full and open competition with a base ordering period of 20 June 2022 through 19 June 2027 and an Option Ordering Period of 20 June 2027 - 19 June 2032. Task orders may be competed under fair opportunity (providing all Contract Holders within a Market Segment the opportunity to submit a proposal) or an exception to fair opportunity (such as set-asides for small businesses or applicable small business socioeconomic categories). The cumulative ceiling of this unrestricted IDIQ contract vehicle is $10 billion. To date, the accumulated awarded task order value (including future unexercised option periods) is over $690 million across 61 task orders. Task Orders have been issued by a growing number of end users including DHACA, the U.S. Army Medical Research Acquisition Activity (now integrated into DHACA), the Naval Supply Systems Command, and the Uniformed Services University of the Health Sciences. When excluding the task orders simply providing a minimum guarantee to the existing Contract Holders, 61 task orders have been issued off this contract vehicle with 8 task orders being set aside for the 8(a) Program and 15 task orders being awarded to an 8(a) Participant (based on the most recent representations at the contract level). 42 task orders have been awarded so far to small businesses under this contract vehicle. Of the 61 task orders, 95% were awarded during the Government Fiscal Years 2024 - 2026. Please see attachments for further details.
-Pre-SolicitationOpen
Please see attached Sources Sought. Questions & Answers attached.
-Market Research11/12/2026
The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform the fiscal year 2027 (FY27) Alzheimer’s Research Program (AZRP) research focus areas and associated research funding opportunities. Although FY27 federal funds have not yet been appropriated, the AZRP is collecting this information solely to support strategic program planning. This inquiry does not commit the program to incorporating this feedback into FY27 or any future AZRP funding opportunities. The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public. This RFI should not be construed as a solicitation or an obligation on the part of the AZRP or the Department of War (DoW). BACKGROUND: The CDMRP represents a unique partnership between the U.S. Congress, the military, and the public to fund innovative and impactful medical research in targeted program areas. The CDMRP AZRP’s vision is to mitigate the impact of Alzheimer's and related dementias associated with TBI, military, and diverse risks. The AZRP’s mission is to fund impactful, solution-oriented research to address critical needs and improve quality of life for Service Members, Veterans, their Families, and the public who are living with Alzheimer's disease and related dementias. Appropriations for the AZRP from FY11-26 totaled $228 million. As of October 2026, FY27 funds for the AZRP have not been appropriated. If appropriated, the CDMRP will utilize its two-tier review process https://cdmrp.health.mil/about/2tierRevProcess) to efficiently manage the AZRP. Additional information about the AZRP can be found here: https://cdmrp.health.mil/azrp/ RESPONSE INSTRUCTIONS: Please provide responses to this RFI by clicking on the following link: https://www.surveymonkey.com/r/FY27-AZRP-RFI
-Market Research12/04/2026

Additional Details

Solicitation Number

36C24525Q0106

Archive Date

Dec 4, 2024

Office Address

LINTHICUM, MD, 21090